Does valerian root help with anxiety during perimenopause?

Valerian root (Valeriana officinalis) has a plausible mechanism for reducing anxiety in perimenopause, and some clinical evidence supports its use, though the research is modest and mostly focused on generalized anxiety rather than perimenopause specifically.

How valerian affects the nervous system

The most relevant mechanism involves GABA, the brain's primary calming neurotransmitter. Valerenic acid, one of valerian's active compounds, inhibits the breakdown of GABA at GABA-A receptors, allowing more GABA to remain active. This is a similar pathway to how benzodiazepine medications work, though valerian's effect is considerably weaker and does not carry the same dependency risks. During perimenopause, progesterone levels decline significantly. Progesterone is converted in the brain to allopregnanolone, a potent positive modulator of GABA-A receptors. As allopregnanolone drops, the nervous system becomes more reactive and harder to calm. Valerian may partially compensate for this shift by supporting GABA-A activity through a different route.

What the research shows

A clinical study by Andreatini et al. (2002) found that valerenic acid reduced anxiety symptoms in people with generalized anxiety disorder. While this study was not conducted in perimenopausal women specifically, the underlying neurochemical overlap is meaningful. Valerian also has adenosine receptor activity, which may contribute to its calming effect independently of GABA. The research here is limited, and most studies are small. The evidence is promising but not definitive, and effects tend to be modest compared to prescription anxiolytics.

One practical limitation is timing. Because valerian is sedating, it is best suited to evening use. Taking it during the day to manage daytime anxiety is not ideal, as it may cause drowsiness that interferes with work or driving. For daytime anxiety, other approaches including therapy, breathwork, exercise, and provider-evaluated medication options are generally better suited.

Valerian for anxiety vs. sleep

Valerian's strongest evidence base is for improving sleep quality, not anxiety directly. The sleep improvement effect is relevant here because perimenopausal anxiety is often worse in women who are also sleep-deprived. A vicious cycle can develop in which anxiety disrupts sleep, and poor sleep makes anxiety worse the following day. If this pattern sounds familiar, addressing the sleep disruption with valerian in the evening may provide an indirect benefit to daytime anxiety by breaking that cycle. This is a reasonable application of the supplement, even where the direct anxiety evidence is thin.

Dosing considerations

Studies have generally used standardized extracts in the range of 300 to 600 mg taken in the evening. Talk to your healthcare provider about what form and timing might be appropriate for you. Consistency matters, as effects may take two to four weeks to become apparent with regular use.

Tracking how your anxiety shifts over time, using a tool like PeriPlan, can help you see whether consistent use is producing a real change or whether the effect is too subtle to detect. Logging sleep quality alongside anxiety levels gives a fuller picture of how these two factors interact for you.

Safety and drug interactions

Valerian is generally considered safe for short-term use of four to eight weeks. Common side effects include drowsiness, headache, and vivid dreams. The most significant concern is its interaction with other CNS depressants. Combining valerian with alcohol, benzodiazepines, opioids, antihistamines, or prescription sleep medications amplifies sedation and can be dangerous. Do not drive or operate heavy machinery after taking valerian. It is not recommended during pregnancy, and its safety with long-term use beyond eight weeks has not been well established. Valerian is not considered hormone-sensitive and does not appear to affect estrogen pathways, so it does not carry the warnings that apply to herbs like red clover or chasteberry.

When to see a provider

Anxiety during perimenopause can range from mild to severely disabling. If your anxiety is interfering with daily functioning, relationships, or sleep, a healthcare provider can evaluate whether the cause is primarily hormonal, assess whether hormone therapy might help, and discuss treatment options that have stronger evidence. Cognitive behavioral therapy has robust evidence for anxiety at this life stage. Valerian is a reasonable addition to a broader strategy, but it should not replace medical evaluation for significant anxiety.

This content is for informational purposes only and does not replace medical advice. Always consult your healthcare provider about your specific situation.